208 related articles for article (PubMed ID: 19457596)
21. Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
Saito T; Fujiuchi S; Tao Y; Sasaki Y; Ogawa K; Suzuki K; Tada A; Kuba M; Kato T; Kawabata M; Kurashima A; Sakatani M;
Infection; 2012 Dec; 40(6):661-7. PubMed ID: 22956473
[TBL] [Abstract][Full Text] [Related]
22. [Porphyria cutanea tarda revealed by voriconazole].
Hickman G; Duval A; Picard C; Petit A
Ann Dermatol Venereol; 2010 Jan; 137(1):36-9. PubMed ID: 20110066
[TBL] [Abstract][Full Text] [Related]
23. [Rebound after ABPA treatment with voriconazole].
Mulliez P; Croxo C; Saint-Georges FR
Rev Mal Respir; 2010 Sep; 27(7):786-7. PubMed ID: 20863984
[No Abstract] [Full Text] [Related]
24. Adverse reactions to voriconazole.
Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
[TBL] [Abstract][Full Text] [Related]
25. Voriconazole therapy in children with cystic fibrosis.
Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
[TBL] [Abstract][Full Text] [Related]
26. Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge.
Jensen SG; Nielsen TL
Clin Respir J; 2008 Oct; 2(4):245-6. PubMed ID: 20298342
[No Abstract] [Full Text] [Related]
27. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
Mouas H; Lutsar I; Dupont B; Fain O; Herbrecht R; Lescure FX; Lortholary O;
Clin Infect Dis; 2005 Apr; 40(8):1141-7. PubMed ID: 15791514
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of ABPA: a place for voriconazole and omalizumab?].
Mulliez P
Rev Mal Respir; 2010 Sep; 27(7):670-2. PubMed ID: 20863965
[No Abstract] [Full Text] [Related]
29. VFEND® (voriconazole)-associated hypoglycaemia without identified drug interaction.
Lyoen M; Rostain F; Grimault A; Minello A; Sgro C
Fundam Clin Pharmacol; 2013 Oct; 27(5):570-1. PubMed ID: 22834415
[TBL] [Abstract][Full Text] [Related]
30. [Clinical case of the month. Pulmonary aspergillosis: chimic necrotizing aspergillosis].
Golinval O; Louis R
Rev Med Liege; 2007 Dec; 62(12):704-6. PubMed ID: 18286944
[TBL] [Abstract][Full Text] [Related]
31. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
Glackin L; Leen G; Elnazir B; Greally P
Ir Med J; 2009 Jan; 102(1):29. PubMed ID: 19284017
[TBL] [Abstract][Full Text] [Related]
32. Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.
Denning DW; Griffiths CE
Clin Exp Dermatol; 2001 Nov; 26(8):648-53. PubMed ID: 11722447
[TBL] [Abstract][Full Text] [Related]
33. The safety of voriconazole.
Potoski BA; Brown J
Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
[No Abstract] [Full Text] [Related]
34. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Denning DW; Ribaud P; Milpied N; Caillot D; Herbrecht R; Thiel E; Haas A; Ruhnke M; Lode H
Clin Infect Dis; 2002 Mar; 34(5):563-71. PubMed ID: 11807679
[TBL] [Abstract][Full Text] [Related]
35. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
36. Voriconazole-associated myositis.
Shanmugam VK; Matsumoto C; Pien E; Rosen J; Kumar P; Whelton S; Steen V
J Clin Rheumatol; 2009 Oct; 15(7):350-3. PubMed ID: 20009971
[TBL] [Abstract][Full Text] [Related]
37. Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
Pakyz A; Bearman G
Consult Pharm; 2008 Oct; 23(10):804-8. PubMed ID: 19032016
[TBL] [Abstract][Full Text] [Related]
38. Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Perfect JR; Marr KA; Walsh TJ; Greenberg RN; DuPont B; de la Torre-Cisneros J; Just-Nübling G; Schlamm HT; Lutsar I; Espinel-Ingroff A; Johnson E
Clin Infect Dis; 2003 May; 36(9):1122-31. PubMed ID: 12715306
[TBL] [Abstract][Full Text] [Related]
39. Voriconazole in newborns.
Kohli V; Taneja V; Sachdev P; Joshi R
Indian Pediatr; 2008 Mar; 45(3):236-8. PubMed ID: 18367773
[TBL] [Abstract][Full Text] [Related]
40. A case series of unilateral orbital aspergillosis in three cats and treatment with voriconazole.
Smith LN; Hoffman SB
Vet Ophthalmol; 2010 May; 13(3):190-203. PubMed ID: 20500720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
